Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

CP/CPPS is defined by pelvic/perineal pain, urinary symptoms, and/or sexual dysfunction lasting >3 months without evidence of bacterial infection. It affects up to 10% of men and significantly impacts quality of life. Management is multimodal and personalized.

NIH Classification

Symptoms

Evaluation

Treatment & Management (UPOINT Framework)

1. Urinary: alpha-blockers (tamsulosin), 5-alpha-reductase inhibitors for BPH overlap

2. Psychosocial: CBT, mindfulness, antidepressants/anxiolytics

3. Organ-specific: anti-inflammatory agents (NSAIDs, COX-2 inhibitors), phytotherapy (quercetin), heat/contrast baths

4. Infection: targeted antibiotics if culture-positive (fluoroquinolones, TMP-SMX) but avoid long empiric courses in CP/CPPS

5. Neurologic/Systemic: neuromodulators (gabapentin, pregabalin, duloxetine), low-dose naltrexone

6. Tenderness (musculoskeletal): pelvic floor physical therapy, trigger point release, dry needling

Additional Therapies

Lifestyle

Living with CP/CPPS

Complications

Research & Future Directions

Current studies explore immune dysregulation, microbiome shifts, neuromodulation, and regenerative therapies.

Experimental & Emerging Treatments

Track CP/CPPS with Diagnoza.care

Own Your Pelvic Pain Plan – Log pain/urinary scores, triggers, sexual symptoms, medications, antibiotics, PT sessions, psychological therapy, and urology visits; capture side effects; and let the AI companion highlight patterns that guide UPOINT-based adjustments.
Medical Disclaimer: Informational only. Work with your urologist, pelvic floor therapist, pain specialist, and mental health provider to tailor a multimodal treatment plan and rule out other pathologies. Sources: American Urological Association, European Association of Urology, Chronic Prostatitis Collaborative Research Network